Company: RGNX
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0000950170-25-052069
Chunk: 28

Company: REGENXBIO Inc.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 28
---
 our fiscal year ended December 31, 2024 for his service as a director and is not included in the 2024 Director Compensation Table below. Fees Earned or Paid in Cash In 2024, pursuant to our compensation program for non-employee directors, each member of the Board who was not an employee received the following annual cash compensation for Board services, as applicable, paid in quarterly installments in arrears:

| Description of Service                                                  |     |         Cash 
 Compensation 
          ($) |
| Chairman of the Board                                                   |     |       35,000 |
| Lead Independent Director                                               |     |       25,000 |
| Member of the Board                                                     
 (including the Chairman of the Board and the Lead Independent Director) |     |       45,000 |

In addition to the cash compensation described above, each member of the Board who served on the Audit Committee, Compensation Committee or Nominating and Corporate Governance Committee received additional cash compensation as follows, paid in quarterly installments in arrears:

| Committee                                     |     | Role             |     |         Cash 
 Compensation 
          ($) |
| Audit Committee                               |     | Committee Chair  |     |       20,000 |
|                                               |     | Committee Member |     |       10,000 |
| Compensation Committee                        |     | Committee Chair  |     |       15,000 |
|                                               |     | Committee Member |     |        7,500 |
| Nominating and Corporate Governance Committee |     | Committee Chair  |     |       10,000 |
|                                               |     | Committee Member |     |        5,000 |

The annual cash compensation to our directors is pro-rated for any partial year of service on our Board or as a committee chair or committee member. Equity Awards The Company seeks to maintain competitive executive compensation in order to attract the most qualified candidates. The Company's non-employee director compensation program includes equity awards granted to directors annually and upon appointment to the Board as follows: Non-employee directors receive an annual equity award grant with an aggregate value of $275,000. Of this amount, 75% is in the form of non-statutory stock options and 25% of the value is in the form of restricted stock units ("RSUs"), in each case rounded down to the nearest whole share. The exercise price per share price for each option is equal to the fair market value of our common stock on the grant date. The options vest in equal monthly installments over the